Spotfire Provides Dana-Farber Cancer Institute with Unprecedented Insight into Cancer Vaccine Clinical Trials
When Karen Maloney, Business Development Manager of the Cancer Vaccine Centre (CVC) at Dana-Farber Cancer Institute (Dana-Farber) in Boston decided to investigate the competitive landscape of the cancer vaccine field, she looked to a strategic planning and marketing MBA class at Babson College in Wellesley, MA for help with the research project. There she met Xiaohong Cao, whose bioinformatics background led to the decision to focus on clinical vaccine trials as representative of potential competition. This became Dana-Farber CVC?s first organized attempt to assess in-depth the cancer vaccine market.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Fast and Efficient Sialic Acid Clone Selection Using Lectin-Based High-Throughput Screening
June 2nd 2025Glycosylation is a common and critical post-translational modification that affects protein function and therapeutic efficacy, making its monitoring and accurate quantification essential for drug development.
